324 related articles for article (PubMed ID: 22547449)
1. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.
O'Shannessy DJ; Yu G; Smale R; Fu YS; Singhal S; Thiel RP; Somers EB; Vachani A
Oncotarget; 2012 Apr; 3(4):414-425. PubMed ID: 22547449
[TBL] [Abstract][Full Text] [Related]
2. Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.
Driver BR; Barrios R; Ge Y; Haque A; Tacha D; Cagle PT
Arch Pathol Lab Med; 2016 Jul; 140(7):682-5. PubMed ID: 26599808
[TBL] [Abstract][Full Text] [Related]
3. Interobserver agreement and assay reproducibility of folate receptor α expression in lung adenocarcinoma: a prognostic marker and potential therapeutic target.
Bremer RE; Scoggin TS; Somers EB; O'Shannessy DJ; Tacha DE
Arch Pathol Lab Med; 2013 Dec; 137(12):1747-52. PubMed ID: 23570254
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents.
Cagle PT; Zhai QJ; Murphy L; Low PS
Arch Pathol Lab Med; 2013 Feb; 137(2):241-4. PubMed ID: 22984810
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor alpha: a new tool in the diagnosis and treatment of lung cancer.
Wood LD
Oncotarget; 2012 Jul; 3(7):668-9. PubMed ID: 22914202
[TBL] [Abstract][Full Text] [Related]
6. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
7. Associations between TS, TTF-1, FR-α, FPGS, and overall survival in patients with advanced non-small-cell lung cancer receiving pemetrexed plus carboplatin or gemcitabine plus carboplatin as first-line chemotherapy.
Grønberg BH; Lund-Iversen M; Strøm EH; Brustugun OT; Scott H
J Thorac Oncol; 2013 Oct; 8(10):1255-64. PubMed ID: 24457236
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of FRA expression in epithelial cancers using AQUA(®) technology.
O'Shannessy DJ; Gustavson M; Chandrasekaran LK; Dolled-Filhart M; Somers EB
Biomark Med; 2013 Dec; 7(6):933-46. PubMed ID: 24266829
[TBL] [Abstract][Full Text] [Related]
9. Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.
Sheikh UN; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 May; 44(5):369-76. PubMed ID: 26875861
[TBL] [Abstract][Full Text] [Related]
10. Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients.
Christoph DC; Reyna-Asuncion B; Hassan B; Tran C; Maltzman JD; O'Shannessy DJ; Gauler TC; Wohlschlaeger J; Schuler M; Eberhardt WE; Hirsch FR
Clin Lung Cancer; 2014 Sep; 15(5):320-30.e1-3. PubMed ID: 24993594
[TBL] [Abstract][Full Text] [Related]
11. High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer.
Sterlacci W; Wolf D; Savic S; Hilbe W; Schmid T; Jamnig H; Fiegl M; Tzankov A
Hum Pathol; 2012 Mar; 43(3):339-49. PubMed ID: 21840566
[TBL] [Abstract][Full Text] [Related]
12. Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed.
Christoph DC; Asuncion BR; Hassan B; Tran C; Maltzman JD; O'Shannessy DJ; Wynes MW; Gauler TC; Wohlschlaeger J; Hoiczyk M; Schuler M; Eberhardt WE; Hirsch FR
J Thorac Oncol; 2013 Jan; 8(1):19-30. PubMed ID: 23242435
[TBL] [Abstract][Full Text] [Related]
13. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
[TBL] [Abstract][Full Text] [Related]
14. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
15. Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.
Ohgino K; Soejima K; Yasuda H; Hayashi Y; Hamamoto J; Naoki K; Arai D; Ishioka K; Sato T; Terai H; Ikemura S; Yoda S; Tani T; Kuroda A; Betsuyaku T
Lung Cancer; 2014 Jan; 83(1):90-6. PubMed ID: 24239165
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma.
Luu M; Sabo E; de la Monte SM; Greaves W; Wang J; Tavares R; Simao L; Wands JR; Resnick MB; Wang L
Hum Pathol; 2009 May; 40(5):639-44. PubMed ID: 19200576
[TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.
Chang H; Yang Y; Lee JS; Jheon SH; Kim YJ; Chung JH
Clin Lung Cancer; 2019 Jan; 20(1):7-12.e1. PubMed ID: 30017644
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer.
Situ D; Wang J; Ma Y; Zhu Z; Hu Y; Long H; Rong T
Med Oncol; 2011 Dec; 28 Suppl 1():S596-604. PubMed ID: 21116877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
